Min Han Selected Research

Enzymes

1/2022	Peptide nano-blanket impedes fibroblasts activation and subsequent formation of pre-metastatic niche.
3/2020	Evaluation of H2S-producing enzymes in cerebrospinal fluid and its relationship with interleukin-6 and neurologic deficits in subarachnoid hemorrhage.
4/2019	Stimulus-responsive nanoscale delivery systems triggered by the enzymes in the tumor microenvironment.
1/2019	Mitoxantrone-preloaded water-responsive phospholipid-amorphous calcium carbonate hybrid nanoparticles for targeted and effective cancer therapy.
2/2008	Biliverdin reductase mediates hypoxia-induced EMT via PI3-kinase and Akt.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Min Han Research Topics

Disease

70	Neoplasms (Cancer) 04/2024 - 10/2006
14	Fibrosis (Cirrhosis) 01/2024 - 04/2011
14	Alzheimer Disease (Alzheimer's Disease) 02/2023 - 09/2008
13	Breast Neoplasms (Breast Cancer) 08/2023 - 10/2012
8	Glioblastoma (Glioblastoma Multiforme) 05/2023 - 07/2013
8	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 05/2006
8	Tuberculosis (Tuberculoses) 06/2017 - 01/2010
7	Inflammation (Inflammations) 04/2024 - 06/2017
7	Infections 01/2024 - 05/2010
7	Neoplasm Metastasis (Metastasis) 07/2022 - 01/2012
6	Hypoxia (Hypoxemia) 07/2022 - 02/2008
6	IGA Glomerulonephritis (IGA Nephropathy) 02/2022 - 01/2015
5	Cognitive Dysfunction 04/2024 - 01/2016
5	Parkinson Disease (Parkinson's Disease) 08/2022 - 01/2012
5	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2012
4	Reperfusion Injury 01/2024 - 08/2014
4	Body Weight (Weight, Body) 01/2024 - 01/2018
4	Adenocarcinoma 10/2023 - 09/2008
4	Proteinuria 09/2023 - 09/2021
4	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2009
4	Spinal Cord Injuries (Spinal Cord Injury) 10/2022 - 08/2014
4	Glioma (Gliomas) 03/2022 - 02/2013
4	Carcinoma (Carcinomatosis) 07/2021 - 11/2008
4	Obesity 01/2021 - 01/2016
3	Poisoning 01/2024 - 01/2022
3	Brain Ischemia (Cerebral Ischemia) 01/2024 - 01/2020
3	Type 2 Diabetes Mellitus (MODY) 02/2023 - 01/2020
3	Stroke (Strokes) 01/2022 - 01/2020
3	Melanoma (Melanoma, Malignant) 01/2022 - 01/2012
3	Hypercholesterolemia 01/2022 - 01/2013
3	Hypertension (High Blood Pressure) 01/2021 - 10/2013
3	Hemorrhage 01/2021 - 04/2006
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2019 - 08/2015
3	Starvation 01/2017 - 11/2011
3	Colorectal Neoplasms (Colorectal Cancer) 08/2016 - 11/2004
3	Pulmonary Tuberculosis 12/2014 - 06/2011
2	Neuroinflammatory Diseases 04/2024 - 01/2023
2	Ischemic Stroke 12/2023 - 01/2022
2	Atherosclerosis 11/2023 - 01/2013
2	Sepsis (Septicemia) 10/2023 - 08/2020
2	Membranous Glomerulonephritis (Membranous Nephropathy) 09/2023 - 01/2022
2	Acute Lung Injury 09/2023 - 08/2020
2	Hematologic Neoplasms (Hematological Malignancy) 07/2023 - 01/2020

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 02/2023 - 10/2005
17	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2022 - 01/2011
12	Peptides (Polypeptides)IBA 07/2022 - 05/2010
10	Biomarkers (Surrogate Marker)IBA 10/2023 - 03/2014
9	Liposomes (Liposome)IBA 05/2023 - 09/2008
8	Messenger RNA (mRNA)IBA 01/2024 - 08/2009
7	MicellesIBA 10/2020 - 05/2010
7	AutoantibodiesIBA 01/2016 - 07/2010
6	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024 - 02/2008
6	LipidsIBA 12/2023 - 08/2015
5	CreatinineIBA 07/2023 - 10/2016
5	Therapeutic UsesIBA 12/2022 - 01/2018
5	MicroRNAs (MicroRNA)IBA 01/2022 - 11/2011
5	EnzymesIBA 01/2022 - 02/2008
4	ginsenoside Rg1IBA 04/2024 - 04/2006
4	BoronIBA 04/2024 - 01/2019
4	Blood Glucose (Blood Sugar)IBA 01/2024 - 01/2022
4	Indicators and Reagents (Reagents)IBA 10/2023 - 10/2020
4	AntigensIBA 09/2023 - 11/2015
4	InterferonsIBA 05/2023 - 11/2014
4	Long Noncoding RNAIBA 01/2023 - 01/2020
4	CholesterolIBA 01/2022 - 01/2020
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2018
4	PolymersIBA 01/2022 - 11/2011
4	NanodiamondsIBA 10/2020 - 10/2018
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 07/2011
3	TRPC6 Cation ChannelIBA 01/2024 - 01/2023
3	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 01/2022
3	Uric Acid (Urate)IBA 11/2023 - 01/2020
3	HydrogelsIBA 06/2023 - 02/2017
3	IntegrinsIBA 05/2023 - 01/2022
3	HDL CholesterolIBA 01/2022 - 01/2020
3	Mitochondrial DNA (mtDNA)IBA 01/2022 - 11/2019
3	SolutionsIBA 01/2022 - 10/2012
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2012
3	Immunoglobulin G (IgG)IBA 05/2021 - 01/2011
3	CytokinesIBA 01/2021 - 11/2008
3	Hyaluronic Acid (Hyaluronan)IBA 01/2021 - 01/2018
3	LigandsIBA 01/2021 - 01/2012
3	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021 - 09/2008
3	polyglycerolIBA 10/2020 - 10/2018
3	Folic Acid (Vitamin M)FDA LinkGeneric 08/2019 - 07/2013
3	AcidsIBA 01/2018 - 01/2012
3	Poloxamer (Poloxamer 407)IBA 11/2016 - 05/2010
3	polycaprolactoneIBA 10/2014 - 01/2011
2	Transient Receptor Potential ChannelsIBA 01/2024 - 01/2023
2	Emodin (Archin)IBA 09/2023 - 08/2020
2	AlbuminsIBA 07/2023 - 01/2022
2	Coloring Agents (Dyes)IBA 07/2023 - 04/2009

Therapy/Procedure

27	Therapeutics 04/2024 - 05/2009
19	Drug Therapy (Chemotherapy) 05/2023 - 04/2009
5	Boron Neutron Capture Therapy 04/2024 - 01/2019
4	Immunotherapy 04/2023 - 11/2008
3	Radiotherapy 04/2024 - 01/2019
3	Neoadjuvant Therapy 08/2023 - 01/2019
2	Ligation 09/2023 - 08/2020
2	Punctures 09/2023 - 08/2020